Result of AGM

EDX Medical Group PLC

28 September 2026

 

28 September 2026

EDX Medical Group plc

("EDX Medical" or the "Company")

Results of Annual General Meeting

CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, today announces the results of its Annual General Meeting, held at the Henrietta Room, 1 Wimpole Street, London, W1G 0AE on 28 September 2026 at 2.00 p.m.

All resolutions were passed as a poll. Resolutions 1 - 11 were passed as ordinary resolutions and resolutions 12 and 13 were passed as special resolutions.

The number of votes cast for and against each of the resolutions proposed, and the number of votes withheld were as follows:

Resolution	Votes for	%	Votes against	%	Votes withheld
Resolution 1 (Ordinary) To receive the Annual Report and Accounts of the Company for the year ended 31 March 2026 together with the Directorsʼ reports and auditorʼs report on those accounts.	181,843,821	100.00	0	0	7,720,023
Resolution 2 (Ordinary) To accept the Remuneration Committee Report for the financial year ended 31 March 2026, as set out in the Company's Annual Report and Accounts for the year ended 31 March 2026.	181,841,341	>99.99	2,480	<0.01	7,720,023
Resolution 3 (Ordinary) To accept the Directorsʼ Remuneration Policy, as set out in the Company's Annual Report and Accounts for the year ended 31 March 2026.	169,927,624	>99.99	2,459	<0.01	19,633,761
Resolution 4 (Ordinary) To re-appoint Jason Holt as a director of the Company.	181,840,525	>99.99	2,517	<0.01	7,720,802
Resolution 5 (Ordinary) To re-appoint Dr Michael Hudson as a director of the Company.	181,841,125	>99.99	2,433	<0.01	7,720,286
Resolution 6 (Ordinary) To re-appoint Professor Sir Christopher Evans as a director of the Company.	181,841,143	>99.99	2,433	<0.01	7,720,268
Resolution 7 (Ordinary) To re-appoint Professor Trevor Jones as a director of the Company.	181,841,085	>99.99	2,473	<0.01	7,720,286
Resolution 8 (Ordinary) To re-appoint Martin Walton as a director of the Company.	181,841,085	>99.99	2,473	<0.01	7,720,286
Resolution 9 (Ordinary) To re-appoint PKF Littlejohn LLP as auditor of the Company.	181,839,576	100.00	0	0	7,724,268
Resolution 10 (Ordinary) To authorise the Directors to determine the fees payable to the auditor	181,839,494	>99.99	82	<0.01	7,724,268
Resolution 11 (Ordinary) To authorise the Directors to allot shares in the Company.	181,818,769	99.99	19,273	0.01	7,725,802
Resolution 12 (Special) To disapply statutory pre-emption rights generally.	181,229,094	99.66	609,421	0.34	7,725,329
Resolution 13 (Special) To disapply statutory pre-emption rights pursuant to an acquisition or other capital investment.	181,080,100	99.69	567,026	0.31	7,916,718

As at 28 September 2026, there were 431,373,146 ordinary shares in issue with no shares held in treasury, resulting in total voting rights of 431,373,146. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

The full text of each resolution is available in the Notice of Annual General Meeting, published on our website.

​
For enquiries, please contact:

EDX Medical Group plc
Dr Mike Hudson (Chief Executive Officer)	[phone]
Canaccord Genuity Limited (Nominated Adviser and Broker)
Stuart Andrews	[phone]
Media House International
Ramsay Smith Gary McQueen	[phone] [e-mail] + 44 (0)7834 694609 [e-mail]
IFC Advisory (Investor Relations)
Graham Herring Tim Metcalfe	[phone]

 

END